Table 2. IC50 of WCN-21, WND and WNP in different cell lines with different treatment time.
| Cell lines | Topotecan | WCN-21 | WND | WNP | |
|---|---|---|---|---|---|
| Hep3B | 24 h | 0.4616 ± 0.02 | 0.27 ± 0.010 | 0.1674 ± 0.0032 | 0.09328 ± 0.0013 |
| 48 h | 0.1121 ± 0.0024 | 0.01838 ± 0.0028 | 0.007459 ± 0.001 | 0.003129 ± 0.0017 | |
| HepG2 | 24 h | 1.594 ± 0.0206 | 0.5014 ± 0.0036 | 0.4035 ± 0.037 | 0.1375 ± 0.0062 |
| 48 h | 0.2847 ± 0.009 | 0.1836 ± 0.049 | 0.1007 ± 0.0038 | 0.05663 ± 0.058 | |
| Huh 7 | 24 h | 0.5 ± 0.069 | 0.4017 ± 0.009 | 0.1719 ± 0.0032 | 0.07261 ± 0.0002 |
| 48 h | 0.1167 ± 0.048 | 0.07221 ± 0.012 | 0.05807 ± 0.0201 | 0.02625 ± 0.0405 | |
| L02 | 24 h | > 0.5 | > 0.5 | > 0.5 | > 0.5 |
| 48 h | > 0.5 | > 0.5 | > 0.5 | 0.490 ± 0.093 | |
Data are expressed as mean ± SD of three independent samples.